OÜ PharmaNineteen
RegisteredKey figures
Ratios
2025Profit exceeds EBITDA because of financial income (e.g. dividends or interest), which EBITDA does not include.
Summary: OÜ PharmaNineteen
What kind of company is it?
OÜ PharmaNineteen (registry code 16009865) is a private limited company (OÜ). The company was entered in the Commercial Register in 2020 and has been registered for 6 years. Registered location: Mustamäe linnaosa, Tallinn, Harju maakond. According to the latest annual report, the main activity is retail sale of pharmaceutical products (EMTAK 47731). The company is registered for VAT (VAT number EE102272419).
How is the company doing financially?
Revenue in financial year 2025 was 2 265 049 €, up 6,8% on the previous year (2 120 345 €). From 2020/21 to 2025, revenue grew by an average of 9,6% per year. This is the company's highest revenue among the published years (2020/21–2025). Financial year 2025 ended with a loss of 52 632 €. The company was profitable in 1 of the 5 published financial years. In financial year 2025 the company had 4 employees (3 a year earlier). Revenue per employee was 566 262 €.
What do the latest quarters show?
According to the Tax and Customs Board, turnover in Q3 2026 was 635 731 €, up 17,9% on the same quarter a year earlier. The company had 15 employees in that quarter. Labour taxes paid in the quarter: 19 552 €. Based on labour taxes, the estimated average gross salary in Q3 2026 was about 950 € per month.
Who runs the company and who owns it?
The company has one management board member. The sole owner of the company is a private individual.
What should you look out for?
Equity was negative at the end of financial year 2025 (−121 095 €). Equity is below half of the share capital (2500 €); in this case the Commercial Code requires measures to restore equity.
Where does the data come from and how fresh is it?
Register data (name, address, legal form, management board and owners) come from the Commercial Register of the Centre of Registers and Information Systems (RIK); changes are read from RIK every night. Financial figures come from annual reports; the latest report (financial year 2025) was filed on 30.06.2026. Quarterly turnover, employee numbers and labour taxes come from the open data of the Tax and Customs Board (EMTA); latest quarter Q3 2026. Changes, averages and ratios are calculated by entity.ee from open data and are not an official assessment.
Quarterly figures
| Quarter | Revenue | Number of employees | Labour taxes |
|---|---|---|---|
| Q3 2026 | 635 731 € | 15 | 19 552 € |
| Q2 2026 | 586 756 € | 14 | 17 248 € |
| Q1 2026 | 662 079 € | 15 | 18 750 € |
| Q4 2025 | 610 477 € | 15 | 18 787 € |
| Q3 2025 | 539 290 € | 16 | 22 835 € |
| Q2 2025 | 532 241 € | 16 | 20 599 € |
| Q1 2025 | 527 480 € | 16 | 15 760 € |
Source: Tax Board open data — based on VAT returns, may not exactly match revenue in the annual report. Updated quarterly.
Summary of financial statements2021–2025
| 2020/21 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Sales revenue | 1 567 002 | 1 738 938 | 1 808 682 | 2 120 345 | 2 265 049 |
| Net profit | 3354 | −32 380 | −9032 | −32 904 | −52 632 |
| Retained earnings | — | 3354 | −29 027 | −38 059 | −70 963 |
| Total assets | 647 139 | 704 971 | 341 869 | 334 166 | 387 563 |
| Total liabilities | 641 285 | 731 497 | 377 428 | 402 629 | 508 658 |
| Total equity | 5854 | −26 526 | −35 559 | −68 463 | −121 095 |
| Employees | 1 | 2 | 3 | 3 | 4 |
| Average gross salary (monthly) | 2235 | 2580 | 2280 | 3123 | 2988 |
| Calculated dividend | — | 0 | 0 | 0 | 0 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Risks and obligationsAll clear
Data from public registers, not a credit rating.
Connections graph
Annual reportsPDF, XBRL
Loading list of reports…
Source: e-Business Register (RIK). Files open/download directly from the official register.
Related companies
- Selver AS622 m €
- ORLEN Eesti OÜ609 m €
- AS Alexela555 m €
- Coop Eesti Keskühistu549 m €
- aktsiaselts Olerex543 m €